RMD - ResMed - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RMD is currently covered by 7 analysts with an average price target of $290.18. This is a potential upside of $18.18 (6.68%) from yesterday's end of day stock price of $272.

ResMed's activity chart (see below) currently has 164 price targets and 138 ratings on display. The stock rating distribution of RMD is 47.37% HOLD and 52.63% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 72.45% with an average time for these price targets to be met of 168.78 days.

Highest price target for RMD is $330, Lowest price target is $240, average price target is $275.6.

Most recent stock forecast was given by LAURA SUTCLIFFE from CITI on 17-Sep-2025.

Split History since 2000:

8/31/10 2 for 1

10/3/05 2 for 1

4/3/00 2 for 1

Currently out of the existing stock ratings of RMD, 9 are a HOLD (47.37%), 10 are a BUY (52.63%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$330

$58 (21.32%)

$285

25 days ago
(17-Sep-2025)

7/8 (87.5%)

$56.71 (20.75%)

38

Buy

$270

$-2 (-0.74%)

$250

2 months 27 days ago
(15-Jul-2025)

14/14 (100%)

$16.28 (6.42%)

98

Buy

$290

$18 (6.62%)

5 months 19 days ago
(23-Apr-2025)

17/17 (100%)

$54.9 (23.35%)

363

Hold

$248

$-24 (-8.82%)

$260

5 months 19 days ago
(23-Apr-2025)

3/3 (100%)

$12.9 (5.49%)

70

Hold

$240

$-32 (-11.76%)

$250

7 months 8 days ago
(04-Mar-2025)

2/2 (100%)

$17.12 (7.68%)

54

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RMD (ResMed) average time for price targets to be met?

On average it took 168.78 days on average for the stock forecasts to be realized with a an average price target met ratio 72.45

Which analyst has the current highest performing score on RMD (ResMed) with a proven track record?

MATTHEW MISHAN

Which analyst has the most public recommendations on RMD (ResMed)?

Matthew Mishan works at KEYBANK and has 9 price targets and 5 ratings on RMD

Which analyst is the currently most bullish on RMD (ResMed)?

Laura Sutcliffe with highest potential upside - $58

Which analyst is the currently most reserved on RMD (ResMed)?

Matt O'brien with lowest potential downside - -$215

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?